Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1999 5
2000 11
2001 10
2002 6
2003 5
2004 4
2005 6
2006 2
2007 1
2008 4
2009 6
2010 5
2011 4
2012 5
2013 4
2014 7
2015 5
2016 3
2017 7
2018 7
2019 6
2020 8
2021 15
2022 5
2023 8
2024 3
2025 9
2026 3

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

144 results

Results by year

Filters applied: . Clear all
Page 1
[Therapeutic drug monitoring].
Le Guellec C, Bentué-Ferrer D; groupe STP de la SFPT. Le Guellec C, et al. Therapie. 2010 Jan-Feb;65(1):13-5. Therapie. 2010. PMID: 20443240 French. No abstract available.
Niveau de preuve du suivi therapeutique pharmacologique de la ribavirine.
Solas C, Paré M, Quaranta S, Stanke-Labesque F; pour le groupe Suivi Thérapeutique Pharmacologique de la Société Francaise de Pharmacologie et de Thérapeutique. Solas C, et al. Among authors: stanke labesque f. Therapie. 2011 May-Jun;66(3):221-30. doi: 10.2515/therapie/2011036. Therapie. 2011. PMID: 27393202 French.
Suivi thérapeutique pharmacologique des 6-thioguanine nucléotides dans les maladies inflammatoires cryptogéniques de l'intestin : intérêt et limites.
Jourdil N, Fonrose X, Boulieu R, Stanke-Labesque F; pour le groupe Suivi Thérapeutique Pharmacologique de la Société Française de Pharmacologie et de Thérapeutique. Jourdil N, et al. Among authors: stanke labesque f. Therapie. 2010 May-Jun;65(3):177-86. doi: 10.2515/therapie/2010030. Therapie. 2010. PMID: 27392984 French.
Pharmacokinetics of Subcutaneous and Intravenous Ceftriaxone in an Older Population: The PhASAge Study.
Roubaud-Baudron C, Fauchon H, Stanke-Labesque F, Paccalin M, Breilh D, Grégoire N, Forestier E, Ferry T, Gavazzi G, Goutelle S; Infectiology and Geriatrics InterGroup (SPILF-SFGG GInGer). Roubaud-Baudron C, et al. Among authors: stanke labesque f. Open Forum Infect Dis. 2025 May 30;12(6):ofaf313. doi: 10.1093/ofid/ofaf313. eCollection 2025 Jun. Open Forum Infect Dis. 2025. PMID: 40567999 Free PMC article. Clinical Trial.
Digital pharmacological twins: Bridging multi-scale modelling and artificial intelligence for precision medicine: The DIGPHAT consortium.
Woillard JB, Benzekry S, Josse J, White-Koning M, Chatelut E, Comets E, Lemaitre F, Franck B, Gregoire M, Stanke-Labesque F, Zohar S, Ursino M, Battail C; DIGPHAT consortium. Woillard JB, et al. Among authors: stanke labesque f. Therapie. 2025 Sep 26:S0040-5957(25)00112-X. doi: 10.1016/j.therap.2025.09.006. Online ahead of print. Therapie. 2025. PMID: 41076365
Vascular biology of the isoprostanes.
Cracowski JL, Devillier P, Durand T, Stanke-Labesque F, Bessard G. Cracowski JL, et al. Among authors: stanke labesque f. J Vasc Res. 2001 Mar-Apr;38(2):93-103. doi: 10.1159/000051036. J Vasc Res. 2001. PMID: 11316945 Review.
144 results